跳至主要内容
临床试验/NCT05425316
NCT05425316已完成不适用

Analysis of Acoustic, Lexical, and Syntactic Speech Features in Hepatic Encephalopathy

University of Michigan2 个研究点 分布在 1 个国家目标入组 251 人开始时间: 2021年10月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
251
试验地点
2
主要终点
Change in Psychometric Hepatic Encephalopathy Score (PHES) from Baseline to 6 Months

研究概览

简要总结

This is an observational study that will test the clinical significance of speech features in patients with cirrhosis. It aims to assess if speech is associated with cognitive function at baseline, if speech predicts changes in cognition, and if speech predicts future events of hepatic encephalopathy (cirrhosis-related confusion), as well as to assess the dynamics of speech over time, especially with episodes of overt hepatic encephalopathy (OHE) and treatment interventions.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • for Patients with Cirrhosis:
  • Cirrhosis, as diagnosed by imaging, elastography, biopsy, or decompensation
  • Able to provide informed consent in English

排除标准

  • for Patients with Cirrhosis:
  • Neurodegenerative disorder (other than hepatic encephalopathy) including Alzheimer's disease and dementia
  • Prior stroke or Transischemic Attack (TIA)
  • English not primary language for communication
  • Inclusion Criteria for Patients without Cirrhosis:
  • Able to provide informed consent in English
  • Fibroscan with stiffness <7 kPa
  • Exclusion Criteria for Patients without Cirrhosis:
  • Alanine Aminotransferase (ALT) or Aspartate Aminotransferase (AST) >5 times the upper limit of normal in the last year
  • History of cirrhosis by imaging or histology or clinical decompensation
  • Neurodegenerative disorder (other than hepatic encephalopathy) including Alzheimer's disease and dementia
  • Prior stroke or TIA

结局指标

主要结局

Change in Psychometric Hepatic Encephalopathy Score (PHES) from Baseline to 6 Months

时间窗: 6 Months

A well-validated pen-and-paper neurocognitive assessment tool to identify minimal Hepatic Encephalopathy (HE). Scores range from -15 to +5; values farther from 0 (normalized average) represent more significant deviation from the norm. Positive scores indicate better performance.

Change in Psychometric Hepatic Encephalopathy Score (PHES) from Baseline to 12 Months

时间窗: 12 Months

A well-validated pen-and-paper neurocognitive assessment tool to identify minimal Hepatic Encephalopathy (HE). Scores range from -15 to +5; values farther from 0 (normalized average) represent more significant deviation from the norm. Positive scores indicate better performance.

Speech Assessments

时间窗: 12 Months

Recorded speech tasks comprising 3 sections: paragraph reading test, picture description test, and animal naming test.

Time to Overt Hepatic Encephalopathy (HE)

时间窗: 12 Months

Patient-reported HE episodes and HE episodes resulting in patient admission to University of Michigan hospital. Information collected includes: Date of symptom onset, duration of HE episode, and changes to medications.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Patricia Bloom

Assistant Professor

University of Michigan

研究点 (2)

Loading locations...

相似试验